CERVICAL CANCER

This study tested a radioactive drug called [225Ac]-FPI-1434 in people with advanced solid tumours that had not responded to standard treatments. The goal was to find a safe dose and see if it could shrink tumours. The trial was stopped early, so results are limited. Participants…

This study tested a new drug called OC-001, either by itself or combined with avelumab (an immunotherapy), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The trial was stopped early, and only 73 people were e…

This study tested an experimental drug called INCB099318 in 105 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are limited…

This study looked at whether adding a specific chemotherapy combination (carboplatin and paclitaxel) after standard chemoradiation could help people with advanced cervical cancer that has spread to lymph nodes in the abdomen. The trial planned to enroll 21 participants but was st…

This early-phase study tested a new drug called PHN-010, which delivers a powerful toxin directly to cancer cells. It involved 26 adults with advanced lung, colon, endometrial, ovarian, or cervical cancers that had already been treated. The main goals were to check safety and fin…

This study tested a combination of two drugs—toripalimab (an immunotherapy) and chidamide (a targeted therapy)—in women with advanced cervical cancer that had come back or spread. The goal was to see if the combo was safe and could shrink tumors. Only 5 women enrolled before the …

This trial tested a drug called tisotumab vedotin, alone or with other medicines, in 214 people with cervical cancer that had come back or spread. The goal was to find the best dose and see if the drug could shrink tumors. The study was stopped early, but results help guide futur…

This early-phase study tested a new drug called SO-C101, alone or with pembrolizumab, in 115 people with advanced solid tumors (like lung, kidney, or skin cancer) that stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study …

This study tested two experimental drugs (AGEN2034 alone or with AGEN1884) in 211 women with advanced cervical cancer that came back after standard chemotherapy. The goal was to see if the drugs could shrink tumors. The trial was terminated early, so results are limited. Particip…

This study compared two methods for taking a small tissue sample from the cervix (endocervical curettage) in women with abnormal Pap smears. The goal was to see if using a soft brush (cytobrush) causes less pain than the standard metal tool (Kevorkian curette) while still getting…

This study aimed to see if offering help with unmet social needs—like food, housing, or transportation—could increase the number of low-income, uninsured, or Medicaid patients who attend their colposcopy appointment after an abnormal cervical cancer screening. The trial planned t…

This study aimed to see if DNA from cervical cancer tumors can be found in the blood, which might help doctors detect early signs of cancer spread. Researchers planned to enroll 26 patients with cervical cancer before treatment. The study was terminated early, so results are limi…